0001437749-25-023439.txt : 20250725 0001437749-25-023439.hdr.sgml : 20250725 20250724174017 ACCESSION NUMBER: 0001437749-25-023439 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250725 DATE AS OF CHANGE: 20250724 EFFECTIVENESS DATE: 20250725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-552749 FILM NUMBER: 251148026 BUSINESS ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 D 1 primary_doc.xml X0708 D LIVE 0001401040 DiaMedica Therapeutics Inc. 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN MINNESOTA 55305 (763) 496-5454 CANADA (FEDERAL LEVEL) None DiaMedica Inc. Corporation true Rick Pauls 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Director Scott Kellen 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Lorianne Masuoka 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer David J. Wambeke 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Executive Officer Michael R. Giuffre 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Director Richard Kuntz 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Director Tanya N. Lewis 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Director James T. Parsons 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Director Daniel O'Connor 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Director Charles P. Semba 301 Carlson Parkway Suite 210 Minneapolis MN MINNESOTA 55305 Director Biotechnology Decline to Disclose 06b false 2025-07-23 false true false 0 30100000 30100000 0 false 14 0 0 0 false DiaMedica Therapeutics Inc. /s/ Scott Kellen Scott Kellen Chief Financial Officer and Secretary 2025-07-24